These results demonstrate that thermal targeting of the Bac-ELP1-H1 polypeptide to the brain tumor site resulted in very significant reduction in tumor progression, delayed onset of tumor-induced neurological deficits, and at least doubled survival time relative to control tumors. This evidence concerns the gene ELP1 and neoplasm.